{"id":19535,"date":"2012-11-02T19:41:33","date_gmt":"2012-11-02T19:41:33","guid":{"rendered":"http:\/\/www.eugenesis.com\/getting-ready-for-a-biopharma-partnering-deal-with-linda-pullan-from-pullan-consulting-video\/"},"modified":"2012-11-02T19:41:33","modified_gmt":"2012-11-02T19:41:33","slug":"getting-ready-for-a-biopharma-partnering-deal-with-linda-pullan-from-pullan-consulting-video","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/getting-ready-for-a-biopharma-partnering-deal-with-linda-pullan-from-pullan-consulting-video.php","title":{"rendered":"Getting Ready for a BioPharma Partnering Deal with Linda Pullan from Pullan Consulting &#8211; Video"},"content":{"rendered":"<p><br \/>Getting Ready for a BioPharma Partnering Deal with Linda Pullan from Pullan Consulting<br \/>View this ShareVault webinar with Linda Pullan from Pullan Consulting on Getting Ready for a Bio-Pharma Oarnt Agenda: \u00bb Should you partner now? \u00bb Valuation basics \u00bb Process to a deal \u00bb Negotiations prep \u00bb Negotiations \u00bb Term sheets \u00bb On to the full agreement Speaker Biography: Linda M. Pullan, Ph.D. offers biotech and pharmaceutical companies consulting in all aspects of partnering through Pullan Consulting (www.pullanconsulting.com). Linda has a Ph.D. in Biochemistry and a BS in Chemistry. Linda has more than 20 years of drug industry experience, beginning in drug discovery at Monsanto\/Searle\/now Pfizer and ICI\/Zeneca\/now AstraZeneca. After doing licensing at what is now AstraZeneca, Dr. Pullan continued as head of oncology and hematology licensing for Amgen. She then joined Kosan Biosciences as VP of Business Development and experienced all the tasks of out-licensing and business development in a small company. For several years, she has been providing companies help in identification, evaluation, valuation, negotiation and strategy for partnering in or out. She has an extensive deal sheet ranging from company acquisitions to Phase III compounds and from preclinical candidates to technologies, with both in- and out-licensing. She writes a free monthly newsletter Pullan #39;s Pieces, with tidbits of science and business for about 3600 readers. Interested readers may sign up by sending an email to <a href=\"mailto:lpullan@msn.com\">lpullan@msn.com<\/a>. Learning Objectives: \u00bb Basics of Valuation \u00bb Dealmaking ...From:ShareVaultViews:0    0ratingsTime:55:29More inEducation<\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.youtube.com\/watch?v=scCrE-pXdFw\" title=\"Getting Ready for a BioPharma Partnering Deal with Linda Pullan from Pullan Consulting - Video\">Getting Ready for a BioPharma Partnering Deal with Linda Pullan from Pullan Consulting - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Getting Ready for a BioPharma Partnering Deal with Linda Pullan from Pullan Consulting View this ShareVault webinar with Linda Pullan from Pullan Consulting on Getting Ready for a Bio-Pharma Oarnt Agenda: \u00bb Should you partner now? \u00bb Valuation basics \u00bb Process to a deal \u00bb Negotiations prep \u00bb Negotiations \u00bb Term sheets \u00bb On to the full agreement Speaker Biography: Linda M.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/getting-ready-for-a-biopharma-partnering-deal-with-linda-pullan-from-pullan-consulting-video.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577469],"tags":[],"class_list":["post-19535","post","type-post","status-publish","format-standard","hentry","category-biochemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/19535"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=19535"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/19535\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=19535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=19535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=19535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}